Paradigm Capital Management Inc’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70.8M Sell
822,299
-123,500
-13% -$11.1M 2.71% 10
2025
Q4
$82.6M Sell
945,799
-1,001
-0.1% -$76K 3.48% 7
2025
Q3
$54.2M Buy
946,800
+4,500
+0.5% +$259K 2.35% 11
2025
Q2
$55.6M Sell
942,300
-7,000
-0.7% -$452K 2.71% 9
2025
Q1
$69.5M Hold
949,300
3.86% 7
2024
Q4
$78.5M Sell
949,300
-22,100
-2% -$1.74M 3.64% 8
2024
Q3
$69.5M Sell
971,400
-30,000
-3% -$2.12M 3.08% 9
2024
Q2
$68.6M Sell
1,001,400
-10,000
-1% -$597K 3.13% 9
2024
Q1
$54.3M Buy
1,011,400
+19,600
+2% +$1.05M 2.6% 12
2023
Q4
$52.9M Buy
991,800
+7,700
+0.8% +$375K 2.75% 12
2023
Q3
$48.9M Buy
984,100
+250,000
+34% +$14M 2.8% 13
2023
Q2
$43.7M Buy
734,100
+20,000
+3% +$1.14M 2.5% 16
2023
Q1
$40.4M Buy
714,100
+41,700
+6% +$2.67M 2.68% 16
2022
Q4
$49.9M Sell
672,400
-11,100
-2% -$756K 3.3% 6
2022
Q3
$40.7M Sell
683,500
-4,500
-0.7% -$271K 2.93% 8
2022
Q2
$38.6M Sell
688,000
-7,400
-1% -$486K 2.62% 11
2022
Q1
$51.3M Buy
695,400
+41,300
+6% +$2.87M 2.77% 12
2021
Q4
$47.2M Buy
654,100
+39,100
+6% +$2.84M 2.11% 16
2021
Q3
$47.1M Buy
615,000
+6,900
+1% +$554K 2.42% 14
2021
Q2
$47.1M Buy
608,100
+7,800
+1% +$555K 2.26% 15
2021
Q1
$37M Buy
600,300
+18,600
+3% +$1.18M 1.92% 20
2020
Q4
$37.9M Sell
581,700
-15,600
-3% -$897K 2.27% 14
2020
Q3
$29.6M Buy
597,300
+7,500
+1% +$387K 2.49% 11
2020
Q2
$28.1M Sell
589,800
-116,300
-16% -$5.61M 2.58% 10
2020
Q1
$30M Sell
706,100
-233,300
-25% -$11.5M 3.63% 3
2019
Q4
$55.3M Buy
939,400
+500
+0.1% +$27.1K 4.27% 2
2019
Q3
$48M Sell
938,900
-5,800
-0.6% -$276K 4.3% 2
2019
Q2
$40M Buy
944,700
+211,200
+29% +$9.17M 3.64% 3
2019
Q1
$36.2M Hold
733,500
3.18% 4
2018
Q4
$31.7M Buy
733,500
+1,300
+0.2% +$64.9K 3.12% 4
2018
Q3
$41.6M Sell
732,200
-3,300
-0.4% -$174K 3.27% 3
2018
Q2
$37.1M Hold
735,500
2.99% 6
2018
Q1
$36.6M Hold
735,500
3.1% 6
2017
Q4
$30.2M Sell
735,500
-3,500
-0.5% -$123K 2.58% 7
2017
Q3
$22M Sell
739,000
-47,100
-6% -$1.44M 1.9% 17
2017
Q2
$26.1M Sell
786,100
-7,800
-1% -$245K 2.34% 11
2017
Q1
$23.5M Sell
793,900
-235,000
-23% -$6.41M 2.21% 12
2016
Q4
$25.5M Buy
1,028,900
+18,325
+2% +$416K 2.48% 8
2016
Q3
$22.8M Buy
1,010,575
+49,575
+5% +$1.17M 2.39% 10
2016
Q2
$22.9M Buy
961,000
+8,500
+0.9% +$204K 2.79% 4
2016
Q1
$22.6M Buy
952,500
+3,000
+0.3% +$73.3K 2.63% 5
2015
Q4
$26.4M Buy
949,500
+35,800
+4% +$899K 2.95% 3
2015
Q3
$18.9M Buy
913,700
+29,375
+3% +$744K 2.3% 9
2015
Q2
$22.7M Buy
884,325
+23,575
+3% +$597K 2.34% 11
2015
Q1
$21.7M Sell
860,750
-35,150
-4% -$856K 2.24% 8
2014
Q4
$21.3M Sell
895,900
-90,250
-9% -$2M 2.1% 8
2014
Q3
$19.4M Buy
986,150
+151,825
+18% +$3.12M 1.61% 17
2014
Q2
$20M Buy
834,325
+214,975
+35% +$5.19M 1.48% 16
2014
Q1
$16.5M Sell
619,350
-50,450
-8% -$1.2M 1.19% 20
2013
Q4
$13.5M Buy
669,800
+163,700
+32% +$3.04M 0.81% 35
2013
Q3
$8.84M Sell
506,100
-6,000
-1% -$104K 0.53% 73
2013
Q2
$8.63M Buy
+512,100
New +$7.9M 0.4% 108

Other funds holding GMED

Paradigm Capital Management Inc's GMED Position: Q1 2026 in Review

Paradigm Capital Management Inc reduced its Globus Medical (GMED) stake by 13% in Q1 2026, selling an estimated $11.1M and leaving 822,299 shares worth $70.8M. The position accounts for 2.71% of the portfolio, ranked #10.

Paradigm Capital Management Inc first reported a position in GMED in Q2 2013 and has held it in 52 quarters since. The position peaked at $82.6M in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Paradigm Capital Management Inc held 822,299 shares of Globus Medical worth $70.8M as of Q1 2026.
  • Paradigm Capital Management Inc sold 123,500 Globus Medical shares in Q1 2026, an estimated $11.1M.
  • Globus Medical made up 2.71% of Paradigm Capital Management Inc's portfolio in Q1 2026, its #10 holding.
  • Paradigm Capital Management Inc first reported a position in Globus Medical in Q2 2013 and has held it in 52 quarters since.
  • Paradigm Capital Management Inc's Globus Medical position peaked at $82.6M in Q4 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Paradigm Capital Management Inc's 13F filing for Q1 2026, filed 14 May 2026.